Chen; Weizao

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; Weizao.The latest application filed is for "human monoclonal antibodies specific for flt3 and uses thereof".

Company Profile

6.13.15

Chen; Weizao - Frederick MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Human monoclonal antibodies against LAG3 and uses thereof Grant 11,339,218 - Chen , et al. May 24, 2	2022-05-24
Human Monoclonal Antibodies Specific For Flt3 And Uses Thereof App 20220127367 - Dimitrov; Dimiter S. ; et al.	2022-04-28
Human monoclonal antibodies specific for FLT3 and uses thereof Grant 11,236,171 - Dimitrov , et al. February 1, 2	2022-02-01
Protease Cleavable Bispecific Antibodies And Uses Thereof App 20210388118 - Chen; Weizao ; et al.	2021-12-16
Human Monoclonal Antibodies Against Lag3 And Uses Thereof App 20210115135 - CHEN; Weizao ; et al.	2021-04-22
Stabilized single human CD4 domains and fusion proteins Grant 10,647,754 - Dimitrov , et al.	2020-05-12
Monomeric Human Igg1 Fc And Bispecific Antibodies App 20190367611 - CHEN; Weizao ; et al.	2019-12-05
Human Monoclonal Antibodies Specific For Flt3 And Uses Thereof App 20190352408 - Dimitrov; Dimiter S. ; et al.	2019-11-21
Bispecific multivalent fusion proteins Grant 10,472,412 - Dimitrov , et al. Nov	2019-11-12
Anti-HIV domain antibodies and method of making and using same Grant 10,287,340 - Dimitrov , et al.	2019-05-14
Bispecific Multivalent Fusion Proteins App 20180118815 - Dimitrov; Dimiter S. ; et al.	2018-05-03
Stabilized Single Human Cd4 Domains And Fusion Proteins App 20180086812 - Dimitrov; Dimiter S. ; et al.	2018-03-29
Human domain antibodies against components of the human insulin-like growth factor (IGF) system Grant 9,657,096 - Dimitrov , et al. May 23, 2	2017-05-23
Anti-hiv Domain Antibodies And Method Of Making And Using Same App 20160207985 - Dimitrov; Dimiter S. ; et al.	2016-07-21
Stabilized Single Human Cd4 Domains And Fusion Proteins App 20160039904 - Dimitrov; Dimiter S. ; et al.	2016-02-11
Anti-HIV domain antibodies and method of making and using same Grant 9,181,327 - Dimitrov , et al. November 10, 2	2015-11-10
Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II) Grant 9,127,056 - Dimitrov , et al. September 8, 2	2015-09-08
Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (igf) System App 20150246967 - Dimitrov; Dimiter S. ; et al.	2015-09-03
Human domain antibodies against components of the human insulin-like growth factor (IGF) system Grant 9,056,907 - Dimitrov , et al. June 16, 2	2015-06-16
High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins Grant 8,911,728 - Dimitrov , et al. December 16, 2	2014-12-16
Monospecific And Bispecific Human Monoclonal Antibodies Targeting Insulin-like Growth Factor Ii (igf-ii) App 20140271646 - Dimitrov; Dimiter S. ; et al.	2014-09-18
High-affinity Fully Functional Soluble Single-domain Human Cd4, Antibodies, And Related Fusion Proteins App 20130108636 - Dimitrov; Dimiter S. ; et al.	2013-05-02
Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (igf) System App 20120195897 - Dimitrov; Dimiter S. ; et al.	2012-08-02
Anti-hiv Domain Antibodies And Method Of Making And Using Same App 20110104163 - Dimitrov; Dimiter S. ; et al.	2011-05-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.